Na. Heerema et al., Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia, J CL ONCOL, 18(22), 2000, pp. 3837-3844
Purpose: Little is known about nonrandom deletions of chromosome bands 13q1
2 to 13q14 (13q12-14) in acute lymphoblastic leukemia (ALL), We determined
the prognostic significance of cytogenetically identified breakpoints in 13
q12-14 in children with newly diagnosed ALL treated on Children's Cancer Gr
oup protocols from 1988 to 1995.
Patients and Methods: Breakpoint in 13q12-14 were identified in 36 (2%) of
the 1,946 cases with accepted cytogenetic data. Outcome analysis used stand
ard life-table methods.
Results: Seventeen patients (47%) with an abnormal 13q12-14 were classified
, according to the National Cancer Institute (NCI), as poor risk, and 15 pa
tients (42%) were standard risk; four(11%)were infants less than 12 months
of age. Eight cases had balanced rearrangements of 13q12-14, 27 patients ha
d a partial loss of 13q, and one held both ct partial gain and a partial lo
ss. The most frequent additional abnormalities among these patients were an
abnormal 12p, a del(bq), a del(9p), a 14q11 breakpoint, and an 11q23 break
point. Nineteen patients were pseudodiploid, 10 were hyperdiploid, and seve
n were hypodiploid. Patients with an abnormal 13q12-14 had significantly wo
rse event-free survival than patients lacking such an abnormality, with est
imates at 6 years of 61% (SD = 14%) and 74% (SD = 1%), respectively (P =.04
; relative risk = 1.74), Overall survival, however, was similar for the two
groups (P =.25). The prognostic effect of an abnormal 13q was attenuated i
n a multivariate analysis adjusted for NCI risk status and ploidy IP =.72),
Conclusion: Aberrations of 13q12-14 may contribute to leukemogenesis of chi
ldhood ALL and confer increased risk of treatment failure but are associate
d with other poor-risk features. (C) 2000 by American Society of Clinical O
ncology.